Structure Therapeutics Incorporation

GPCR

Equity

ISIN null / Valor 124807608

NASDAQ (2026-01-30)

USD 88.45+1.49%

Structure Therapeutics Incorporation
UMushroom community rating:

3.44 8 votes No rating yet

NegativeNeutralPositive

About company

Structure Therapeutics Incorporation leverages advanced technologies in molecular visualization, computational chemistry, and data integration to develop innovative medicines. The company focuses on creating oral small molecule drugs that aim to achieve the efficacy and specificity typically associated with biologic and peptide drugs, while addressing the limitations inherent to these traditional therapies. By integrating cutting-edge scientific techniques, Structure Therapeutics seeks to provide differentiated therapeutic solutions that enhance patient outcomes.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

192%1Y

%3Y

%5Y

Performance

100%1Y

93.7%3Y

93.7%5Y

Volatility

5367 M

Market cap (USD)

789,915

Daily traded volume (Shares)

28.72 / 26.04

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.44

8 votes

Performance:

2.94

Innovation:

4.18

Society:

3.94

Nature:

3.59

Bastien Romanens

Switzerland, 02 Nov 2025

Virgil Zhu

United Kingdom, 27 Oct 2025

really depends on the news about clinical trials

****** Panggabean

United Kingdom, 26 Oct 2025

Strong innovation and a solid cash position, but the stock has been under pressure as R&D costs rise and profitability remains distant. The company’s GLP-1 pipeline offers promise, yet market sentiment reflects uncertainty about near-term returns.

EQUITIES OF THE SAME SECTOR

Ardagh Metal Packaging S.A.

Ardagh Metal Packaging S.A. Valor: 113057696

Annual Return

-50%0%+50%

Risk level

110

-0.90%USD 4.39

Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc Valor: 2056755

Annual Return

-50%0%+50%

Risk level

110

0.89%USD 64.47

Highwoods Properties Inc

Highwoods Properties Inc Valor: 237658

Annual Return

-50%0%+50%

Risk level

110

-0.15%USD 25.85

Bank of Hawaii Corp

Bank of Hawaii Corp Valor: 1415092

Annual Return

-50%0%+50%

Risk level

110

-0.73%USD 74.78

O-I Glass Inc

O-I Glass Inc Valor: 51613592

Annual Return

-50%0%+50%

Risk level

110

0.07%USD 15.28

CNO Financial Group Inc

CNO Financial Group Inc Valor: 11291197

Annual Return

-50%0%+50%

Risk level

110

0.57%USD 42.05

Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corporation Valor: 47953731

Annual Return

-50%0%+50%

Risk level

110

-0.92%USD 38.84

Axos Financial Inc

Axos Financial Inc Valor: 43701281

Annual Return

-50%0%+50%

Risk level

110

4.60%USD 98.99

Equity Commonwealth

Equity Commonwealth Valor: 25033374

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 1.58

Willis Towers Watson PLC

Willis Towers Watson PLC Valor: 30948740

Annual Return

-50%0%+50%

Risk level

110

0.39%USD 317.47

Logos provided by Clearbit

Structure Therapeutics Incorporation

GPCR

ISIN null / Valor 124807608

Structure Therapeutics Incorporation UMushroom community rating:

Bastien Romanens

Virgil Zhu

****** Panggabean

Structure Therapeutics Incorporation
UMushroom community rating: